Tag Archives: 2Year

Takeda eyes Alunbrig earlier lung cancer use as 2-year data trounce Pfizer’s Xalkori

Pfizer’s aging Xalkori is the drug to beat in ALK-positive non-small cell lung cancer arena. And that’s just the arena Takeda is aiming for with earlier use of its own treatment Alunbrig. After 25 months of treatment, Alunbrig cut the risk of disease progression by 51% compared with Xalkori in ALK inhibitor-naïve NSCLC, as assessed by… Read More »

Wrist Blood Pressure Cuff Monitor by Balance, “2017 Update” Ultra Portable High Accuracy Readings, Easy-to-Read LCD, Travel Bag included with Two User Support and 2-Year Warranty

Wrist monitors are more compact and portable-but also more sensitive to proper technique. That’s why we designed our monitor with a built-in Position Assistant that corrects your arm position in real time, and our support team is just a phone call away if you have questions. This wrist monitor makes a great companion to the… Read More »